Navigation Links
Innocoll Appoints Anthony H. Wild Ph.D. to Its Board of Directors
Date:7/21/2008

ASHBURN, Va., July 21 /PRNewswire/ -- Innocoll Inc. today announced that Anthony H. Wild, Ph.D. has been appointed to its board of directors.

Dr. Wild is a co-founder and General Partner of BOWS Pharmaceuticals AG, a Swiss drug-delivery technology company. He is a member of the Boards of Directors of several privately-owned specialty pharmaceutical and biotechnology companies. He also chairs the board of advisors of Ferrer, Freeman and Co., a healthcare private equity firm. He is on the board of advisors of Celtic Therapeutics, a pharmaceutical venture fund and is an advisor to Golden Pond Healthcare Inc., a special acquisitions corporation.

Dr. Wild was the Chairman of MedPointe Pharmaceuticals Inc., a privately-held specialty pharmaceutical company based in Somerset (NJ), until its acquisition by Meda AB of Sweden in 2007. He also served as CEO from 2001 until 2006.

Between 1995 and 2000, Dr Wild worked for the Warner-Lambert Company, of Morris Plains (NJ). Starting as President of Warner-Lambert's Parke-Davis (North America) unit, he was promoted to Executive Vice President and President of its global Pharmaceutical Sector in 1996. Before joining Warner-Lambert, Dr. Wild spent 22 years with the Schering-Plough Corporation in various roles culminating as President of its Japanese operations.

Dr. Wild graduated in 1968 from the University of York where he earned an honors degree in Chemistry. He also holds a Ph.D. degree in physical chemistry from the University of Cambridge (Churchill College).

"We are very fortunate to have Dr. Wild join our board, particularly at this time in Innocoll's aggressive evolution to a world leader in biodegradable surgical products. I have known Tony for a number of years and have found him to be a skillful and successful executive in his prior positions. Innocoll is gaining another professional member to its board to guide the company through this period of ambitious growth," said Rolf Schmid
'/>"/>

SOURCE Innocoll Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Innocoll Announces Dosing of First Patient in a Second US Phase 2 Clinical Trial to Investigate CollaRx(R) BUPIVACAINE SURGICAL IMPLANT for the Management of Post-operative Pain
2. Innocoll Announces Closing of $30 Million Equity Financing Investment
3. AMT Appoints Director Global Marketing and Sales
4. Yongye Biotechnology International, Inc. Appoints New Independent Auditor
5. WuXi PharmaTech (NYSE: WX) Appoints Dr. Debra Yu as VP of Strategy
6. PharmAthene Appoints Jordan P. Karp, J.D. Senior Vice President and General Counsel
7. Bioheart, Inc., Board Appoints Howard J. Leonhardt Chief Executive Officer
8. Transcept Pharmaceuticals Appoints Key Senior Executives
9. WuXi PharmaTech (NYSE: WX) Appoints Mr. Bob Zhu as VP of HR
10. Exiqon Appoints Cynthia French as Chief Scientific Officer and Erik Holmlin as Chief Commercial Officer
11. Stason Pharmaceuticals, Inc. Appoints Diana Wood as Vice President, Business Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/10/2009)... Dendreon Corporation (Nasdaq: DNDN ) announced ... of 15,000,000 shares of its common stock at a ... Dendreon also granted to the underwriters a 30-day option ... common stock to cover overallotments, if any. The ... subject to customary closing conditions. ,, J. P. Morgan ...
(Date:12/10/2009)... (NEI), a division of the National Institutes of Health (NIH), ... fund its development of a non-invasive, passive diffusion-based treatment for ... ... Salt Lake City, UT (PRWEB) December 10, 2009 -- ... Institutes of Health (NIH), awarded a $2.18 million grant to ...
(Date:12/10/2009)... YM BioSciences Inc. (NYSE Amex: YMI ; ... that identifies and advances a diverse portfolio of ... today provided an update on the proposed transaction ... Ltd. into YM, details of which were announced ... of Cytopia has unanimously recommended that its shareholders ...
(Date:12/10/2009)... Dec. 10 Vivakor, Inc. (OTC ... has entered into an exclusive, $5 million ... International, Inc. ( www.regeneca.com ). The ... to a new cutting-edge nutraceutical formulation developed ... of future formulations by Vivakor for Regeneca. ...
Breaking Biology Technology:Dendreon Announces Pricing of Common Stock Offering 2Dendreon Announces Pricing of Common Stock Offering 3NEI Awards a Two-Year $2.18 Million SBIR Grant to Aciont 2NEI Awards a Two-Year $2.18 Million SBIR Grant to Aciont 3YM BIOSCIENCES OFFER FOR CYTOPIA APPROVED TO PROCEED TO SHAREHOLDER VOTE BY AUSTRALIAN COURT 2YM BIOSCIENCES OFFER FOR CYTOPIA APPROVED TO PROCEED TO SHAREHOLDER VOTE BY AUSTRALIAN COURT 3YM BIOSCIENCES OFFER FOR CYTOPIA APPROVED TO PROCEED TO SHAREHOLDER VOTE BY AUSTRALIAN COURT 4Vivakor Receives $5 Million Licensing and Purchase Agreement for Nutraceutical Products 2Vivakor Receives $5 Million Licensing and Purchase Agreement for Nutraceutical Products 3
... the very, very small nanotechnology Americans have a ... of nature, it seems, are failing the moral litmus test ... in the journal Nature Nanotechnology , survey results from ... the perception that nanotechnology is morally acceptable. Those views, according ...
... 5 Yourway Transport,( http://www.yourwaytransport.com ), a premium ... handling needs in the,pharmaceutical, biotechnology and medical/healthcare industries, ... its global customer base. The,expansion includes a new, ... Process. , ...
... BETHESDA, Md., Dec. 5 /PRNewswire-FirstCall/ -- Micromet, ... developing novel, proprietary antibodies for the treatment of cancer, ... and Chief Executive Officer, Dr. Christian Itin, will participate ... Cancer" at the RBC Capital Markets Healthcare Conference on ...
Other Biology Technology:For nano, religion in US dictates a wary view 2For nano, religion in US dictates a wary view 3Yourway Transport Expands 2Micromet to Present at the RBC Capital Markets Healthcare Conference 2Micromet to Present at the RBC Capital Markets Healthcare Conference 3Micromet to Present at the RBC Capital Markets Healthcare Conference 4
(Date:12/13/2009)... led by Yale University researchers has used nanosensors ... the first time. Their findings, which appear December ... Nature Nanotechnology , could dramatically simplify the way ... diseases. , The teamled by Mark ... Applied Science, and Tarek Fahmy, an associate professor ...
(Date:12/11/2009)... Malus orientalis species of wild apples that could be ... Middle East and Central Asia. A new study comparing ... varieties from Georgia and Armenia with previously collected varieties ... and establishes a core collection that will make ... research communities. , To identify and record the genetic ...
(Date:12/11/2009)... Pike, an associate professor of anthropology at the University ... northern Kenya to understand how violence shapes the health ... results of her and her colleagues, research," Documenting the ... of northern Kenya: A conceptual framework," is currently published ... Medicine , in collaboration with the British medical journal ...
Breaking Biology News(10 mins):Scientists use nanosensors for first time to measure cancer biomarkers in blood 2Understanding apples' ancestors 2UA-led study grapples with health effects of low-intensity warfare 2On HIV Testing Day HIVMA calls for health care reform to make testing routine every day 49660 1On HIV Testing Day HIVMA calls for health care reform to make testing routine every day 49660 2VA Secretary Hits the Road to Highlight 22United We Serve 22 Effort 49658 1VA Secretary Hits the Road to Highlight 22United We Serve 22 Effort 49658 2Promising Therapy for Prostate Cancer 49656 1Promising Therapy for Prostate Cancer 49656 2
... smoother and more efficient that exploits the inertia of a ... speed variation, according to research published in the International ... touted as a clean and inexhaustible energy source across the ... output of wind farms can be variable. Proposed measures to ...
... WI, JANUARY 5, 2009 Currently, plant testing ... risks from chemical pesticides to nontarget plants requires ... Protection of the plant development and reproduction are ... of animals. Past research conducted by the USEPA ...
... In 2004 Lyncean Technologies announced the construction of the ... inverse Compton scattering to produce high-intensity, tunable, near-monochromatic x-ray ... protein structure determination to the home laboratorybut it has ... spectrum of x-ray science. , Today, at the ...
Other Biology News:Tilting at wind farms 2First Science from the Compact Light Source: A miniature synchrotron for your home lab 2First Science from the Compact Light Source: A miniature synchrotron for your home lab 3
... This thin foil heat sealing material ... pressure from a screw down heated ... is a useful method for sample ... over the existing seal. Ideal for ...
... product has been developed to significantly increase ... proteins. Stability is increased at room ... centigrade. This product is subjected to ... or azide. This formulation insures consistently ...
... CHEMICON Re-Blot Plus Western Blot Strong Antibody ... antibodies from Western blots that have been ... other isotopes. It is not recommended for ... as it is not possible to effectively ...
...
Biology Products: